Option Care Health (NASDAQ:OPCH) Cut to “Hold” at Citizens Jmp

Citizens Jmp lowered shares of Option Care Health (NASDAQ:OPCH) from a market outperform rating to a hold rating in a research report released on Wednesday, MarketBeat.com reports.

Several other research analysts also recently commented on the stock. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $24.00 target price (down from $26.00) on shares of Option Care Health in a report on Thursday, July 30th. Stephens reaffirmed an “equal weight” rating and issued a $24.00 price target (down from $30.00) on shares of Option Care Health in a research report on Friday, July 17th. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and lifted their price objective for the stock from $28.00 to $32.05 in a research note on Tuesday. Barrington Research cut Option Care Health from an “outperform” rating to a “hold” rating in a research report on Wednesday. Finally, William Blair cut Option Care Health from an “outperform” rating to a “market perform” rating in a research report on Tuesday. Two research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $29.17.

Option Care Health Stock Up 0.1%

OPCH opened at $31.07 on Wednesday. The firm has a market cap of $4.65 billion, a P/E ratio of 23.36, a price-to-earnings-growth ratio of 1.89 and a beta of 0.58. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47. The business has a 50 day moving average price of $24.25 and a 200 day moving average price of $23.64. Option Care Health has a twelve month low of $18.01 and a twelve month high of $36.80.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.43 by $0.02. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%. The company had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same quarter last year, the company posted $0.41 earnings per share. The company’s revenue for the quarter was up 1.9% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Research analysts forecast that Option Care Health will post 1.70 EPS for the current year.

Institutional Trading of Option Care Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Andina Capital Management LLC raised its position in shares of Option Care Health by 2.6% during the fourth quarter. Andina Capital Management LLC now owns 16,320 shares of the company’s stock valued at $520,000 after buying an additional 419 shares during the last quarter. Pacer Advisors Inc. grew its position in Option Care Health by 1.3% during the first quarter. Pacer Advisors Inc. now owns 42,649 shares of the company’s stock worth $1,148,000 after buying an additional 528 shares in the last quarter. Central Pacific Bank Trust Division increased its stake in Option Care Health by 3.9% during the third quarter. Central Pacific Bank Trust Division now owns 14,369 shares of the company’s stock valued at $323,000 after acquiring an additional 540 shares during the period. State of Michigan Retirement System raised its holdings in Option Care Health by 1.6% in the 1st quarter. State of Michigan Retirement System now owns 38,159 shares of the company’s stock valued at $1,027,000 after acquiring an additional 600 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund raised its holdings in Option Care Health by 2.5% in the 1st quarter. Oregon Public Employees Retirement Fund now owns 32,530 shares of the company’s stock valued at $876,000 after acquiring an additional 800 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Key Option Care Health News

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: The proposed CD&R and McKesson buyout provides a clear cash value of $32.05 per share and represents a substantial premium to Option Care Health’s pre-deal trading levels. Option Care Health agrees to $32.05 buyout by CD&R and McKesson
• Positive Sentiment: One analysis argues that Option Care Health may still be undervalued despite the $5.8 billion transaction, supporting the view that the offer could be attractive relative to the company’s underlying business value. Option Care Health stock may be undervalued despite the $5.8 billion buyout
• Neutral Sentiment: JPMorgan reaffirmed a “Neutral” rating, indicating limited expected upside beyond the announced offer price and a focus on deal completion rather than ongoing operating growth. JPMorgan reaffirms neutral rating
• Neutral Sentiment: Analyst price-target coverage remains relevant mainly for gauging the spread to the $32.05 cash consideration, as the pending acquisition limits the importance of standalone valuation targets. Option Care Health analyst price targets
• Negative Sentiment: Several firms have reduced their ratings: Citizens JMP moved to “Hold,” Barrington Research downgraded the stock to “Market Perform,” and Truist cut its rating from “Strong Buy” to “Hold.” The downgrades signal reduced upside after the buyout announcement. Citizens JMP lowers rating to hold Barrington Research downgrade
• Negative Sentiment: Kahn Swick & Foti is investigating whether the $32.05 consideration and sale process were adequate. Such scrutiny could create legal or timing uncertainty, although the investigation does not itself indicate that the transaction will fail. Investor alert regarding the proposed sale

About Option Care Health

Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.